Overall, 66% of patients were statin naïve, 31% had diabetes, 4.5% had eGFR < 60 mL/min/1.73 m2, and 40% were receiving an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. Here, ACE is linked to diabetes mellitus.